Corneal neovascularization: an anti-VEGF therapy review. - Wikidata - awgldk - TriplyDB

Corneal neovascularization: an anti-VEGF therapy review.

Corneal neovascularization: an anti-VEGF therapy review.

http://www.wikidata.org/entity/Q34641522

about

Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis Topical treatments for blepharokeratoconjunctivitis in children High-risk corneal allografts: A therapeutic challenge Bone marrow-derived cells in ocular neovascularization: contribution and mechanisms Corneal neovascularization and biological therapy Human Serum Eye Drops in Eye Alterations: An Insight and a Critical Analysis The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy Topical Use of Angiopoietin-like Protein 2 RNAi-loaded Lipid Nanoparticles Suppresses Corneal Neovascularization In vivo corneal neovascularization imaging by optical-resolution photoacoustic microscopy.Factors regulating capillary remodeling in a reversible model of inflammatory corneal angiogenesis Microfluidic co-cultures of retinal pigment epithelial cells and vascular endothelial cells to investigate choroidal angiogenesis.Vascular endothelial growth factor signaling in hypoxia and inflammation.Immunomodulatory effects of bone marrow-derived mesenchymal stem cells on pro-inflammatory cytokine-stimulated human corneal epithelial cells.Ocular delivery of pRNA nanoparticles: distribution and clearance after subconjunctival injection.Corneal lymphangiogenesis in herpetic stromal keratitis Exploring leptin antagonism in ophthalmic cell models Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review.Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications.Inhibitory effects of (90)Sr/(90)Y β-irradiation on alkali burn-induced corneal neovascularization in rats Nanotechnology in corneal neovascularization therapy--a review Emerging roles for antiangiogenesis factors in management of ocular disease.Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats.Preparation of arginine-glycine-aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization.Galectin-3 Inhibition by a Small-Molecule Inhibitor Reduces Both Pathological Corneal Neovascularization and Fibrosis.Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab.Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy.A microarray whole-genome gene expression dataset in a rat model of inflammatory corneal angiogenesis.Topical treatments for blepharokeratoconjunctivitis in children.Expression of anti-VEGF antibody together with anti-EGFR or anti-FAP enhances tumor regression as a result of vaccinia virotherapy.Minimally invasive microneedles for ocular drug delivery.Growth inhibition of formed corneal neovascularization following Fosaprepitant treatment.Inhibitory effects of regorafenib, a multiple tyrosine kinase inhibitor, on corneal neovascularization.Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.Safety of Cultivated Limbal Epithelial Stem Cell Transplantation for Human Corneal Regeneration.Fingerprick autologous blood: a novel treatment for dry eye syndrome.Investigating the Association between Angiogenic Cytokines and Corneal Neovascularization in Sulfur Mustard Intoxicated Subjects 26 Years after Exposure.Fibroblast growth factor-2 drives and maintains progressive corneal neovascularization following HSV-1 infection.Apatinib-loaded nanoparticles suppress vascular endothelial growth factor-induced angiogenesis and experimental corneal neovascularization.Clinical evaluation and characterisation of corneal vascularisation.

P2860

Q22305863-C7B5E4E2-6EE4-41F5-9907-69AF623295F0 Q24188132-5FC4B00D-1F22-4E6A-B1D9-C3D4164F77E9 Q26751483-FD2E2E71-660B-4C68-AD15-D077107C144F Q26765959-6B98DEF4-9CC3-42A6-ABF4-79EE66757527 Q26776229-CDD221FA-FBE8-433B-AD2D-439595ECA75B Q26778628-AC0B79B5-98C2-4EF3-918D-D1A20D39C417 Q28067341-E738CEA1-9A7E-45B5-B57D-08DD11A1EF3F Q28831101-47257506-071A-4E40-888B-2952A3E0ADFC Q30428844-EFB40BB7-6B61-4091-A61F-9408190C35C6 Q30804219-0A2D38A5-1AFF-45A9-B725-E86DB16B79C4 Q30855748-C32CCEA6-48C1-4887-A65D-8AAA165D91FE Q33721685-942D4A9E-1CB2-4F83-8415-2D8693A8DF83 Q33864175-E0D491DA-0183-4E87-AC1F-C18B6D77EF4C Q34011377-0CB3B894-DC6C-4CFC-BF35-3B665AB76DB4 Q34674612-04AA52F1-3370-47BD-B13B-77E81E2A930A Q35009436-A7437CD4-C2F7-4B9E-9EF6-39896795268E Q35633420-812C6765-C2A5-4E55-B44D-24A183F128CB Q36220259-DF14BF9A-CAF9-476D-B74F-E1C3E62F3951 Q36524407-F42FC585-E3B4-411D-9751-DC2A5CA38702 Q36696450-1185F581-11E0-4D33-9375-7802E92CDC85 Q36696513-915FB13B-523D-4FF5-8AAD-F2B36F005FDB Q36808641-C9C8BE7F-8D9A-4AE8-9E52-8BE56F8B1906 Q37446439-FEA3AF92-5FA5-411F-8643-C39322274F4A Q37573788-92CCD564-DC25-4A5C-AA8F-9418456B30DB Q37579627-73672791-5344-4370-A592-AADAF5F230F6 Q37693888-CF5C2BF2-036C-46C1-9537-5E55882312F1 Q38128390-6DA79A49-8F6B-4300-9477-FE34F09E339A Q38375654-1932A0D8-F567-41D9-96EE-F998E4ACB997 Q38760378-37900050-BC77-49FF-A963-EF37110B1271 Q38845254-B808AA60-BD85-4829-8634-83E76EC3674D Q38916649-D4A4DE3C-392E-41F4-A106-5B5A0ACD749E Q38958273-73E01D1E-1EA8-4AAB-950C-0ECAAFAB389E Q39023803-2C5C194D-EBBD-4C6F-A344-649CF356F8A1 Q39087808-53598829-2919-4242-81E8-A003AAB5FBD6 Q39279363-34F5A68C-242C-4769-9B6C-B53526BFD2CF Q39378640-ABB64372-E8A8-4098-8873-900C494D7ACA Q40043362-23CE33B3-5722-4830-9395-9E5090371BE4 Q40257434-B862E4C0-EC37-445E-BED1-2505248C8E03 Q40971686-01DA2441-31C3-49C0-932D-CEE6B69E9FC3 Q41113827-E39D7A5A-E84E-44AC-B869-B834D99975A7

P2860

Corneal neovascularization: an anti-VEGF therapy review.

http://www.wikidata.org/entity/Q34641522

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Corneal neovascularization: an anti-VEGF therapy review.

@ast

Corneal neovascularization: an anti-VEGF therapy review.

@en

Corneal neovascularization: an anti-VEGF therapy review.

@nl

type

label

Corneal neovascularization: an anti-VEGF therapy review.

@ast

Corneal neovascularization: an anti-VEGF therapy review.

@en

Corneal neovascularization: an anti-VEGF therapy review.

@nl

prefLabel

Corneal neovascularization: an anti-VEGF therapy review.

@ast

Corneal neovascularization: an anti-VEGF therapy review.

@en

Corneal neovascularization: an anti-VEGF therapy review.

@nl

P1433

Q34641522-C9D614B0-05E8-4DD5-84D6-EBA17073A0F8

P1476

Q34641522-F1A78EDA-E103-4C82-BE90-C75B3A247C62

P2093

Q34641522-03A65037-CEFF-445F-8FB1-102B757EC11A

Q34641522-0FBC26AC-7D28-499B-B1ED-C6F4659E2671

Q34641522-3C6C7B5E-1F2D-488F-9166-5B59C9012802

Q34641522-447EDE13-3DC5-43D9-81B9-EFFEAE91D6D3

Q34641522-8C651CB8-4794-46E2-BEA7-EC71D83B9686

Q34641522-9FA71B67-E1C6-4001-97EA-45D61BDDFA0A

P2860

Q34641522-0423A04E-1DFA-409E-8AF2-579E0DC644AA

Q34641522-06A25A2D-A21E-49FA-B32B-AC8B0D0E86C1

Q34641522-0856E3A6-AD5B-4705-A8AD-6F3C00905D9F

Q34641522-08C41097-7363-4641-A658-F2231CFC0938

Q34641522-096C7446-C7D0-4A20-B425-8DE2AF41372D

Q34641522-0F3923AA-7BF9-4B47-99B5-71F8E43BFA05

Q34641522-0FB48CA1-4D2C-44F8-8DEA-A8855234907F

Q34641522-13524C67-CB7C-4062-B77D-399E185DF02E

Q34641522-15C1398C-B970-4D28-9A30-9CC7B03135F0

Q34641522-1C5F3A0E-6510-4B4E-B423-C8981F3192CD

P304

Q34641522-73CA02AB-05CE-4B12-91CA-FB79D26EDC3E

P31

Q34641522-CC56E4B1-CC74-4C2E-BF60-D52BE5CCF938

P356

Q34641522-36FE39B6-B650-4780-97F8-40705ED74EF7

P433

Q34641522-CC6A69D9-DAE5-45FC-A633-D627C6F327C7

P478

Q34641522-C15A0C7C-E386-40A9-8D61-BFB1424CAD87

P577

Q34641522-DB42D347-F11E-4832-8515-D720CCC68724

P698

Q34641522-EF11BB36-26B5-4E75-921C-891BEAAF2DC6

P921

Q34641522-8A88612E-C2C5-43BD-8AD1-1316611F3B56

P932

Q34641522-E70E936C-00AC-423F-8884-C7927FFFFFA8

P356

J.SURVOPHTHAL.2012.01.007

P1433

Survey of Ophthalmology

P1476

Corneal neovascularization: an anti-VEGF therapy review.

@en

P2093

Dimitri T Azar

http://www.w3.org/2001/XMLSchema#string

Elisa Lunde

http://www.w3.org/2001/XMLSchema#string

Jin-Hong Chang

http://www.w3.org/2001/XMLSchema#string

Kyu-Yeon Han

http://www.w3.org/2001/XMLSchema#string

Nitin K Garg

http://www.w3.org/2001/XMLSchema#string

Sandeep Jain

http://www.w3.org/2001/XMLSchema#string

P2860

Use of anti-VEGF adjuvant therapy in cancer: challenges and rationale

VEGF-Trap: a VEGF blocker with potent antitumor effects.

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

Tumor angiogenesis: therapeutic implications

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

The biology of VEGF and its receptors

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

Killing the messenger: short RNAs that silence gene expression

Corneal avascularity is due to soluble VEGF receptor-1

Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial.

P304

415-429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.SURVOPHTHAL.2012.01.007

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22898649

http://www.w3.org/2001/XMLSchema#string

P921

neovascularization

P932

3709023

http://www.w3.org/2001/XMLSchema#string